Side Effects of GLP-1 Medications: What’s Common, What’s Serious

GLP-1 medications have changed the weight-loss conversation in a big way, but they are not side-effect-free. The most common issues are nausea, vomiting, diarrhea, constipation, abdominal pain, and indigestion. FDA prescribing information for Wegovy lists these as common adverse reactions, and BMJ reporting notes that gastrointestinal symptoms can affect a large share of users and are a major reason some people stop treatment. (FDA Access Data)

Why do these symptoms happen? GLP-1 drugs slow gastric emptying and affect appetite and gut-brain signaling, which is part of why they help with weight loss in the first place. Helpful for appetite control? Often yes. Always comfortable? Not exactly. (Obesity Action Coalition)

There are also more serious warnings to know. FDA labeling includes precautions about acute pancreatitis, acute gallbladder disease, and hypoglycemia when used with insulin or insulin secretagogues. Those are not the most common outcomes, but they are important enough that patients and clinicians are told to watch for them carefully. (FDA Access Data)

The balanced take is this: GLP-1s can be very effective, but “effective” does not mean “effortless” or “risk-free.” The best outcomes usually come from pairing medication with protein-forward meals, strength training, hydration, and follow-up care rather than assuming the prescription does every job by itself.

Sources: FDA-approved Wegovy labeling, BMJ, Obesity Action Coalition clinician resource. (FDA Access Data)

Related Articles

• What Is RETA Peptide? A Closer Look at Retatrutide
• MK-677: What to Know About This Non-Peptide Often Lumped Into Peptide Talk
  
• HCG for Weight Loss: What the Claims Get Wrong
  
• What Is GLP-3 Peptide? Understanding the Retatrutide Connection
  
• What Are Natural Peptides for Weight Loss?

‍

‍